1-8 of 8
Anna Hultberg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effect of Efgartigimod IV on Immature Platelet Count Fraction in Primary Immune Thrombocytopenia

Filip Matthijssens, Yoshitaka Miyakawa, Kaichi Nishiwaki, Jaume Ayguasanosa, Lan Lan, Anna Hultberg, Peter Ulrichts
Journal: Blood
Blood (2024) 144 (Supplement 1): 5443.
https://doi.org/10.1182/blood-2024-206889
Published: 2024
Journal Articles

Time to Achieve Platelet Count Response after Intravenous Efgartigimod in Adults with Primary Immune Thrombocytopenia: A Phase 3, Multicenter, Double-Blinded, Placebo-Controlled, Randomized Clinical Trial (ADVANCE IV)

Catherine M. Broome, Vickie McDonald, Yoshitaka Miyakawa, Monica Carpenedo, David J Kuter, Hanny Al-Samkari, James B. Bussel, Anna Hultberg, Filip Matthijssens, Jaume Ayguasanosa, Kristof De Beuf, Francesco Rodeghiero, Marc Michel, Adrian Newland
Journal: Blood
Blood (2023) 142 (Supplement 1): 689.
https://doi.org/10.1182/blood-2023-189125
Published: 2023
Journal Articles

Pharmacokinetic / Pharmacodynamic (PK/PD) Simulations Guide Selection of the Dose for Administration of Efgartigimod Subcutaneously in a Phase 3 Clinical Trial in Patients with Primary Immune Thrombocytopenia

Waleed Ghanima, Vickie McDonald, Shivi Jain, Monica Carpenedo, Esther N. Oliva, Anna Hultberg, Domenica Gandini, Erik Hofman, Tonke Van Bragt, Wim Parys, Benjamin van Hoorick, Yoshitaka Miyakawa, Catherine M. Broome
Journal: Blood
Blood (2021) 138 (Supplement 1): 3165.
https://doi.org/10.1182/blood-2021-153261
Published: 2021
Journal Articles

Safety and Efficacy of Cusatuzumab in Combination with Venetoclax and Azacitidine (CVA) in Patients with Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Eligible for Intensive Chemotherapy; An Open-Label, Multicenter, Phase 1b Study

Gail J. Roboz, Thomas Pabst, Ahmed Aribi, Joseph M. Brandwein, Hartmut Döhner, Walter Fiedler, Domenica Gandini, Michelle Geddes, Jing-Zhou Hou, Angela J. Howes, Anna Hultberg, Eric Huselton, Julie Jacobs, Colleen Kane, Ewa Lech-Marańda, Marieke Louwers, Kerri Nottage, Uwe Platzbecker, Raajit Rampal, Mariya Salman, Priya Shah, Don Stevens, Monic Stuart, Marion Subklewe, Anne Sumbul, Eunice S. Wang, Agnieszka Wierzbowska, Bin Yao, Karen Yee, Hagop Kantarjian, Gautam Borthakur
Journal: Blood
Blood (2021) 138 (Supplement 1): 369.
https://doi.org/10.1182/blood-2021-150371
Published: 2021
Journal Articles

Targeting CD70 with Cusatuzumab Eliminates Acute Myeloid Leukemia Stem Cells in Humans

Adrian F Ochsenbein, MD, Thomas Pabst, MD, Sabine Höpner, PhD, Vera Ulrike Bacher, Magdalena Hinterbrandner, Msc, Yara Banz, Rouven Müller, MD, Markus G. Manz, Prof.Dr.MD, Walid Gharib, David Francisco, Rémy Bruggmann, PhD, Luc Van Rompaey, PhD, Mahan Moshir, MSc, Tim Delahaye, MSc, Domenica Gandini, Ellen Erzeel, Anna Hultberg, PhD, Samson Fung, MD, Hans De Haard, Nicolas Leupin, Carsten Riether, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 234.
https://doi.org/10.1182/blood-2019-129916
Published: 2019
Journal Articles

The Combination of the BCL-2 Antagonist Venetoclax with the CD70-Targeting Antibody Cusatuzumab Synergistically Eliminates Primary Human Leukemia Stem Cells

Carsten Riether, PhD, Tanja Chiorazzo, PhD, Amy J. Johnson, PhD, Christina Diane Drenberg, PhD, Khaja Waheeduddin Syed, BPharm, MS, Mahan Moshir, MSc, Anna Hultberg, PhD, Nicolas Leupin, Hans De Haard, Adrian F Ochsenbein, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3918.
https://doi.org/10.1182/blood-2019-127464
Published: 2019
Journal Articles

Argx-110 Targeting CD70, in Combination with Azacitidine, Shows Favorable Safety Profile and Promising Anti-Leukemia Activity in Newly Diagnosed AML Patients in an Ongoing Phase 1/2 Clinical Trial

Adrian F Ochsenbein, MD, Carsten Riether, PhD, Ulrike Bacher, Rouven Müller, MD, Sabine Höpner, PhD, Yara Banz, Magdalena Hinterbrandner, Msc, Mario Bargetzi, MD, Markus G. Manz, MD, Luc Van Rompaey, PhD, Mahan Moshir, MSc, Tim Delahaye, MSc, Domenica Gandini, MD PhD, Ellen Erzeel, Anna Hultberg, PhD, Samson Fung, MD, Hans De Haard, PhD, Nicolas Leupin, MD, Thomas Pabst, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2680.
https://doi.org/10.1182/blood-2018-99-118302
Published: 2018
Journal Articles

Argx-110 for Treatment of CD70-Positive Advanced Cutaneous T-Cell Lymphoma in a Phase 1/2 Clinical Trial

Martine Bagot, MD PhD, Marie Maerevoet, MD, Pier Luigi Zinzani, MD, Fritz Offner, MD, Franck Morschhauser, MD, Jean-Marie Michot, MD, Vincent Ribrag, MD, Maxime Battistella, MD PhD, Helene Moins, Angelica Calleri, PhD, Stéphane Dalle, MD PhD, Marie Beylot-Barry, MD PhD, Karen Zwaenepoel, PhD, Koen De Winnie, PhD, Anne Marie-Cardine, PhD, Jean-Michel Cayuela, PhD, Valentina Tabanelli, MD, Giovanna Motta, PhD, Federica Melle, PhD, Anna Hultberg, PhD, Domenica Gandini, MD PhD, Teresa Marafioti, MD, Mahan Moshir, MSc, Tim Delahaye, MSc, Piotr Zabrocki, PhD, Karen Silence, PhD, Luc Van Rompaey, PhD, Armand Bensussan, MD PhD, Hans De Haard, PhD, Patrick Pauwels, MD PhD, Nicolas Leupin, MD, Stefano A. Pileri, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1627.
https://doi.org/10.1182/blood-2018-99-118204
Published: 2018